期刊文献+

核小体Th表位和CTLA4Ig双基因共表达真核表达载体的构建 被引量:1

Construction of eukaryotic expression vectors containing nucleosome Th epitope and CTLA4Ig genes
在线阅读 下载PDF
导出
摘要 目的将核小体Th表位与CTLA4Ig融合基因融合,研究CTLA4Ig作为真核表达载体的可行性。方法用touchdownPCR法扩增CTLA4Ig基因,同时引入核小体Th表位(H2B14-28)。将PCR产物连接真核表达载体pcDNA3.1穴+雪,构建pcDNA3.1穴+雪-CTLA4Ig-H2B。将表达质粒转染COS-7细胞,Westernblot检测转染细胞裂解上清中融合蛋白的表达。将构建表达CTLA4Ig-H2B的减毒鼠伤寒沙门氏菌SL7207喂饲BALB/c小鼠,取脾脏进行免疫组化鉴定重组蛋白在动物体内的表达。结果酶切鉴定和基因序列测定显示重组质粒构建成功。在pcDNA3.1穴+雪-CTLA4Ig-H2B质粒转染后48h细胞裂解上清中,检测到CTLA4Ig融合蛋白的表达,该蛋白能与抗人CTLA-4单抗特异结合。重组蛋白在BALB/c小鼠脾脏免疫细胞胞浆中有阳性表达。结论成功构建了能稳定表达核小体Th表位和CTLA4Ig融合基因的真核表达载体。 Objective To study the feasibility of CTLA4Ig as eukaryotic expression vector by fusing nucleosome Th epitope in CTLA4Ig eDNA. Methods Touchdown PCR was used to amplify CTLA4Ig eDNA and introduce nucleosome Th epitope. The PCR product was ligated into the multiple clone site of eukaryotic expression vector peDNA3.1 (+) by gene recombination technique. Then the recombinated plasmid pcDNA3.1 (+)-CTLA4Ig-H2B was transfeeted into COS-7 cells using DOTAP. The expression of fusion protein in the supernatant of the cell disruption was detected with Western blotting. After the attenuated Salmonella Typhimurium SL7207 containing the recombinant expression plasmids peDNA3.1 (+)-CTLA4Ig-H2B immunized BALB/c mice orally,spleens were removed to identify the recombinant proteins expression by immunohistoehemistry. Results Restriction analysis and DNA sequence analysis showed that the nueleosome Th epitope and CTLA4Ig eDNA had been successfully inserted into pcDNA3.1 (+) eukaryotic expression vector. The fusion protein could be detected in the superuatant of cell disruption 48 h after the transfection of peDNA3.1(+)-CTLA4Ig-H2B. This protein specifically bound with human CTLA--4 monoelonal antibody. The fusion protein could be detected in the the cytoplasm of spleen cells. Conclusion The eukaryotic expression vector containing nucleosome Th epitope and CTLA4Ig gene is successfully constructed.
出处 《生物医学工程与临床》 CAS 2006年第6期387-390,F0003,共5页 Biomedical Engineering and Clinical Medicine
基金 国家自然科学基金(30200258)
关键词 核小体 TH表位 CTLA4IG 融合蛋白 nucleosome Th epitope CTLA4Ig fusion protein
  • 相关文献

参考文献13

  • 1Zimmerman R,Radhakrishnan J,Valeri A,et al.Advances in the treatment of lupus nephritis[J].Annu Rev Med,2001,52:63-78.
  • 2Licht R,van Bruggen MC,Oppers-Walgreen B,et al.Plasma levels of nucleosome and nucleosome -autoantibody complexes in murine lupus:effects of disease progression and lipopolyssacharide administration[J].Arthritis Rheum,2001,44(6):1320-1330.
  • 3Liblau R,Tisch R,Bercovici N,et al.Systemic antigen in the treatment of T-cell-mediated autoimmune diseases[J].Immunol Today,1997,18(12):599-604.
  • 4Singh RR.The potential use of peptides and vaccination to treat systemic lupus erythematosus[J].Curr Opin Rheumatol,2000,12(5):399-406.
  • 5Eilat E,Dayan M,Zinger H,et al.The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus[J].Proc Natl Acad Sci USA,2001,98(3); 1148-1153.
  • 6Wu HY,Ward FJ,Staines NA.Histone peptide-induced nasal tolerance:suppression of murine lupus[J].J Immunol,2002,169(2):1126-1134.
  • 7Kang HK,Michaels MA,Berner BR,et al.Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets[J].J Immunol,2005,174(6):3247-3255.
  • 8郝进,郝飞,钟白玉,唐书谦,潘峰,苟俊,徐云升.核小体诱导BALB/c小鼠产生狼疮肾的研究[J].中华皮肤科杂志,2004,37(1):12-14. 被引量:9
  • 9郝进,郝飞,林治华,钟白玉,唐书谦,徐云升,叶庆佾.BALB/C小鼠核小体H2B组蛋白Th细胞表位的鉴定[J].中华风湿病学杂志,2004,8(1):4-7. 被引量:4
  • 10Sirard JC,Niedergang F,Kraehenbuhl JP.Live attenuated salmonella:a paradigm of mucosal vaccines[J].Immunol Rev,1999,171:5-26.

二级参考文献4

共引文献9

同被引文献20

  • 1郝进,郝飞,钟白玉,唐书谦,杨希川,徐云升,叶庆佾.静脉应用核小体H2B表位肽防治小鼠实验性系统性红斑狼疮的研究[J].中华风湿病学杂志,2005,9(2):65-67. 被引量:2
  • 2周春丽,郝进,唐书谦,钟白玉,吴军,贺伟峰,郝飞.人CTLA-4Ig融合基因减毒鼠伤寒沙门菌真核表达载体的构建及表达[J].第三军医大学学报,2006,28(3):243-246. 被引量:2
  • 3周春丽,郝进,唐书谦,钟白玉,叶庆佾,邓军,曾韦锟,郝飞.表达核小体Th表位减毒鼠伤寒沙门菌株的构建[J].临床皮肤科杂志,2006,35(6):363-365. 被引量:1
  • 4Spahn TW,Weiner HL.Mesenteric lymph nodes are critical for the induction of high-dese oral tolerance in the absence of Peyers patches.Ear J Immunol,2002,32:1109-1113.
  • 5Kraal G.Inducing tolerance against antigens through initial contact via the mucous membrane.Ned Tijdschr Geneeskd,2002,146:2406-2409.
  • 6Kang HK,Liu M,Datta SK.Low-dose poptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells.J Immunol,2007,178:7849-7858.
  • 7Carvalho CR,Vaz NM.Indirect effects are independent of the way of tolerance induction.Scand J Immunol,1996,43:613-618.
  • 8Chen Y,Inobe J,Kuchroo VK,et al.Oral tolerance in myelin basic protein T-cell receptor transgenic mice:suppression of autoimmune encephalomyelitis and dese-depondent induction of regulatory cells.Proe Nail Acad Sci USA,1996,93:388-391.
  • 9WU HY.Induction of mucosal tolerance in SLE:a sniff or a sip away from ameliorating lupus? Clin Immunol,2009,130:111-122.
  • 10Kang HK,Miehaels MA,Bemer BR,et al.Very low-dose tolerance with nucleesomal poptides controls lupus and induces potent regulatory T cell subsets.J Immunol,2005,174:324%3255.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部